- Home
- ERII vs BBOT Comparison
ERII vs BBOT Comparison
Compare ERII & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ERII | BBOT |
|---|---|---|
| Founded | 1992 | 2016 |
| Country | United States | United States |
| Employees | N/A | 106 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 595.9M | 605.6M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | ERII | BBOT |
|---|---|---|
| Price | $8.76 | $7.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $17.07 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 1.0M | 386.3K |
| Earning Date | 05-06-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $134,987,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.55 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.83 | $7.00 |
| 52 Week High | $18.31 | $14.87 |
Technical Indicators
Market Signals| Indicator | ERII | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 41.19 |
| Support Level | $8.14 | $7.00 |
| Resistance Level | $11.58 | $8.10 |
| Average True Range (ATR) | 0.47 | 0.50 |
| MACD | 0.11 | 0.00 |
| Stochastic Oscillator | 43.58 | 34.78 |
Price Performance
Historical ComparisonAbout ERII Energy Recovery Inc.
Energy Recovery Inc designs and manufactures energy-saving technologies. The firm uses its proprietary pressure exchanger technology to help customers in multiple industries improve their operations and lower their emissions. Using its proprietary technology, it offers energy recovery devices, including pressure exchangers, pumps, and turbochargers, mainly used for seawater desalination and wastewater treatment. Additionally, the company is involved in the development of emerging technologies, such as the PX G1300 used in industrial and commercial refrigeration applications. The firm's reportable operating segments are: Water, which generates maximum revenue, and Emerging Technologies. Geographically, it generates maximum revenue from the Middle East, and the rest from other markets.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.